Sonoma Allocations’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.46M Sell
1,225
-83
-6% -$84.8K 0.45% 38
2026
Q1
$1.22M Sell
1,308
-135
-9% -$137K 0.42% 42
2025
Q4
$1.52M Buy
1,443
+169
+13% +$162K 0.5% 37
2025
Q3
$1.04M Buy
+1,274
New +$948K 0.38% 37

Other funds holding LLY

Sonoma Allocations's LLY Position: Q2 2026 in Review

Sonoma Allocations reduced its Eli Lilly (LLY) stake by 6.3% in Q2 2026, selling an estimated $84.8K and leaving 1,225 shares worth $1.46M. The position accounts for 0.45% of the portfolio, ranked #38.

Sonoma Allocations first reported a position in LLY in Q3 2025 and has held it in 4 quarters since. The position peaked at $1.52M in Q4 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sonoma Allocations held 1,225 shares of Eli Lilly worth $1.46M as of Q2 2026.
  • Sonoma Allocations sold 83 Eli Lilly shares in Q2 2026, an estimated $84.8K.
  • Eli Lilly made up 0.45% of Sonoma Allocations's portfolio in Q2 2026, its #38 holding.
  • Sonoma Allocations first reported a position in Eli Lilly in Q3 2025 and has held it in 4 quarters since.
  • Sonoma Allocations's Eli Lilly position peaked at $1.52M in Q4 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sonoma Allocations's 13F filing for Q2 2026, filed 8 Jul 2026.